Enhanced acute-phase response and oxidative stress in older adults with type II diabetes

被引:65
|
作者
Arnalich, F
Hernanz, A
López-Maderuelo, D
Peña, JM
Camacho, J
Madero, R
Vázquez, JJ
Montiel, C
机构
[1] Univ La Paz, Hosp Maternal, Med Interna Serv, Madrid 28046, Spain
[2] Univ La Paz, Hosp Maternal, Clin Biochem Serv, Madrid 28046, Spain
[3] Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain
[4] Univ La Paz, Hosp Maternal, Biostat Unit, Madrid 28046, Spain
关键词
lipid peroxides (TBARS); C-reactive protein; interleukin-6; non-insulin-dependent diabetes mellitus; aging;
D O I
10.1055/s-2007-978662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To test whether oxidative stress could promote a systemic acute-phase response in elderly patients with type II diabetes. Design and Methods: In a group of 30 older diabetic patients with poor glycemic control, serum levels of lipid per oxides, measured as thiobarbituric acid-reacting substances (TBARS); C-reactive protein (CRP); interleukin (IL)-6 and the soluble form of its receptor (sIL-6R), were evaluated at baseline and after 2 and 3 months of therapeutic intervention. Thirty asymptomatic, untreated individuals with abnormal fasting glycemia, but otherwise healthy status, of similar age, sex, and weight served as control group. Results: At baseline, glycemia (8.83+/-0.67 mmol/l), HbA(1)C (8.66+/-0.59%). TEARS (8.68+/-1.21 mu mol/l), CRP (16.05+/-3.81 mg/l) IL-6 (5.39+/-1.25 pg/ml) and sIL-6R (1425+/-492 pg/ml) were significantly higher in diabetic patients than in asymptomatic hyperglycemic individuals (p<0.001). After treatment, glycemia significantly decreased with respect to baseline values (-9.82% after 60 days and -13.74% after 90 days), as did serum levels of TEARS (-14.05% and -21.89%, respectively), CRP (-32.71% and -43.86 %), IL-6 (-23.75% and -40.63 %) and sIL-6R (-34.53 % and -8.49%, respectively). In diabetic patients, multiple regression showed, at each time, that TEARS and IL-6 were independently correlated with CRP, considering CRP as the dependent variable. Similar correlations were found in asymptomatic hyperglycemic subjects. Conclusion: These results suggest that oxidative stress might be implicated in promoting a state of low-grade systemic inflammation in elderly patients with type II diabetes.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [1] Oxidative stress and acute-phase response in patients with pressure sores
    Cordeiro, MBC
    An'tonelli, TJ
    da Cunha, DF
    Jordao, AA
    Rodrigues, V
    Vannucchi, H
    [J]. NUTRITION, 2005, 21 (09) : 901 - 907
  • [2] Oxidative stress in response to acute exercise in type 2 diabetes
    Yamakita, T
    Ishii, T
    Yamagami, K
    Fukumoto, M
    Yoshioka, K
    Hosoi, M
    Sato, T
    Tanaka, S
    Satoru, F
    [J]. DIABETES, 2002, 51 : A250 - A250
  • [3] Retinal expression of acute-phase response proteins in diabetes
    Costa, MB
    Coulombe, M
    Toth, I
    Hoehn, T
    Grosu, P
    Gerhardinger, C
    [J]. DIABETES, 2004, 53 : A24 - A24
  • [4] The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction
    Pickup, JC
    Chusney, GD
    Mattock, MB
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (01) : 107 - 112
  • [5] HYPERGLYCEMIA IN THE ACUTE-PHASE OF STROKE AND STRESS-RESPONSE
    TRACEY, F
    STOUT, RW
    [J]. STROKE, 1994, 25 (02) : 524 - 525
  • [6] THE ACUTE-PHASE RESPONSE
    BAUMANN, H
    GAULDIE, J
    [J]. IMMUNOLOGY TODAY, 1994, 15 (02): : 74 - 80
  • [7] The effect of eccentric exercise on acute-phase response oxidative stress and cytokines in young and elderly men
    Sacheck, JM
    Milbury, P
    Walter, MF
    Blumberg, JB
    Roubenoff, R
    [J]. FASEB JOURNAL, 2001, 15 (04): : A417 - A417
  • [8] THE ACUTE-PHASE RESPONSE
    RAYNES, JG
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (01) : 69 - 74
  • [9] Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes
    P. Ebeling
    A. -M. Teppo
    H. A. Koistinen
    J. Viikari
    T. Rönnemaa
    M. Nissén
    S. Bergkulla
    P. Salmela
    J. Saltevo
    V. A. Koivisto
    [J]. Diabetologia, 1999, 42 : 1433 - 1438
  • [10] Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes
    Ebeling, P
    Teppo, AM
    Koistinen, HA
    Viikari, J
    Rönnemaa, T
    Nissén, M
    Bergkulla, S
    Salmela, P
    Saltevo, J
    Koivisto, VA
    [J]. DIABETOLOGIA, 1999, 42 (12) : 1433 - 1438